[1]
Fagiolini, A. and Cuomo, A. 2025. Personalized treatment of depression based on the patient’s psychopatology: the case for intravenous or intramuscular trazodone in the acute treatment of depression with psychomotor agitation, irritability, or insomnia and the subsequent transition to extended-release Trazodone (Contramid®) . Journal of Psychopathology. 30, 4 (Feb. 2025). DOI:https://doi.org/10.36148/2284-0249-N655.